Blood Pressure Management in Eclampsia

Immediate Blood Pressure Management

The European Society of Cardiology recommends aiming to lower blood pressure to <160/105 mmHg within 150-180 minutes to prevent maternal stroke and other hypertensive complications 1, 2
Intravenous labetalol can be started with 20 mg IV bolus, then 40 mg after 10 minutes, then 80 mg every 10 minutes until BP controlled, with a maximum cumulative dose of 300 mg in 24 hours 1, 2, 3
Oral nifedipine can be given as 10-20 mg orally, and repeated as needed, with caution due to the risk of severe hypotension when combined with magnesium sulfate 1, 4, 2

The American College of Obstetricians and Gynecologists recommends magnesium sulfate as mandatory for all eclampsia patients, with a loading dose of 4 g IV over 5 minutes, and maintenance of 1 g/h IV infusion 1, 4, 2
Magnesium sulfate should be continued for 24 hours postpartum, with monitoring for toxicity, including checking deep tendon reflexes, respiratory rate, and urine output 4

Methyldopa is recommended as the first-line agent for chronic management, with a dose of 750 mg to 4 g per day in 3-4 divided doses, due to its long-term safety record in pregnancy 5
Labetalol can be used as an alternative oral agent, with a dose of 100 mg twice daily, increasing to 200-400 mg three times daily, with a maximum of 1200-2400 mg/day 5, 6

Blood pressure should be checked every 15 minutes during acute treatment until stable, then hourly, with monitoring for signs of end-organ damage, including headache, visual changes, oliguria, and pulmonary edema 2
Continuous fetal heart rate monitoring should be performed during acute BP management, with limitation of total fluid intake to 60-80 mL/h to prevent pulmonary edema 4, 3

Diuretics are contraindicated due to reduced plasma volume in eclampsia, and worsened uteroplacental perfusion 1, 4, 5
ACE inhibitors and ARBs should be avoided during pregnancy due to teratogenic effects, but can be used postpartum 6
Sodium nitroprusside is contraindicated due to the risk of fetal cyanide poisoning 3

The American Heart Association recommends 1-2 g IV over 15 minutes for polymorphic VT with QT prolongation, with hypotension listed as a recognized adverse effect in patients with cardiovascular disease 7, 8
The European Society of Cardiology guidelines identify magnesium as causing hypotension when used for analgesia in trauma patients, noting it as a "potential adverse effect" in elderly patients and those with cardiovascular disease 9

The American Heart Association recommends 1-2 g IV over 15 minutes for polymorphic VT with QT prolongation, with hypotension listed as a recognized adverse effect in patients with cardiovascular disease 7, 8
The European Heart Journal explicitly cautions about the drug interaction between magnesium sulfate and nifedipine for blood pressure control in eclampsia, noting the "high risk of uncontrolled hypotension when combined" in patients with pre-eclampsia or eclampsia 10

Blood pressure monitoring is mandatory during magnesium infusion, according to the American Heart Association, to prevent hypotension in patients with cardiovascular disease 7, 8

The European Heart Journal warns that calcium channel blockers, particularly nifedipine, dramatically increase hypotension risk when combined with magnesium sulfate in patients with pre-eclampsia or eclampsia 10